How to Buy Inovio Shares Online in the UK

If you’re based in the UK and wish to buy Inovio shares – the process should take you no more than 10 minutes. Open opening an account with UK broker and making a depositing – it’s then simply a case of deciding how much you wish to invest.

You do, however, need to ensure that your chosen broker offers Inovio shares and that it supports your preferred payment method.

In this guide, we explain the easiest and most cost-effective way of buying Inovio shares online in the UK. We’ll also point you in the direction of the best UK share dealing platforms to make the purchase with.

Step 1: Choose an FCA Regulated Broker to Buy Inovio Shares

Buy inovio shares

In order to buy Inovio shares online in the UK, there are several factors that you need to check off before taking the plunge. At the forefront of this is finding a reliable broker that not only gives you access to US stocks – but one that is regulated, cost-effective, and user-friendly.

We have hand-picked two UK trading platforms in particular that allow you to trade or buy Inovio shares at the click of a button.

1. – Trade Inovio Share CFDs and Pay Nothing in Commission logo

The first option that we think you should consider is that of This popular UK platform allows you to trade CFDs. In other words, you can speculate on the future value of an asset without needing to take ownership.  At – not only does this include thousands of stock CFDs – but other assets like commodities, digital currencies, forex, and indices.

Each and every financial market at the platform can be traded on a commission-free basis. As such, other than the spread – there are no other trading fees to consider. At the time of writing, this stands at just $0.11.  With that said, CFDs are leverage products – meaning that positions kept open past the close of trading will incur overnight financing fees.

As such, you’ll need to build this into your trading costs if you plan to hold your Inovio share position for several days or weeks. Nevertheless, trading  Inovio share CFDs at does come with several perks that you won’t find at a traditional brokerage site. For example, you can trade the shares with leverage of up to 1:5. This means that you can enter a position worth five times more than what you have in your account. also gives you the option of going ‘short’. This allows you to profit if the value of Inovio shares goes down. This would be of particular value if Inovio is unsuccessful with its COV-19 clinical trials. In terms of the fundamentals, requires a minimum deposit of just £20 when you opt for a debit/credit card or e-wallet. Most importantly, this trusted platform is licensed by the FCA and has a great reputation in the trading scene.


  • 0% commission on all markets offered
  • Spreads are often industry-leading
  • Trade everything from stocks and indices to commodities and forex – all via CFDs
  • Minimum deposit of just £20
  • FCA regulated
  • Supported payment methods include debit/credit cards and e-wallets
  • Mobile trading app


  • Does not allow you to invest in shares in the traditional sense
  • Not suited for long-term positions

72.6% of retail investor accounts lose money when trading CFDs with this provider.

2. IG – Buy Inovio Shares From £0 Per Trade

IG is one of the most popular trading platforms in the UK. With the company first offering brokerage services in 1974 – it has built a strong customer base that now runs into the hundreds of thousands. One of the best things about IG is that you have the option of investing in stocks and funds in the traditional sense – while at the same time CFDs and spread betting markets are also offered. This gives you the best of both worlds.

With that said, if you are looking to buy Inovio shares are retain full ownership, IG offers two pricing models. Initially, you will be charged £10 per trade when you buy shares listed in the US. But, if you manage to place at least 3 orders in the previous calendar month – this is reduced to £0 per trade. If opting for Inovio shares in the form of CFDs, then you will pay a variable fee of 2 cents per stock. This does, however, come at a minimum of $15.

In other words, if you purchase less than 750 Inovio shares – you will always pay $15. In terms of key features, IG is very strong when it comes to educational materials. It explains key market terms and strategies in a user-friendly manner – which is great if you are just starting out in the world of online investments. The platform also offers a plethora of research and analysis tools.

If you’re planning to buy Inovio shares while on the move – IG offers a mobile app on both Android and iOS devices. The latter, however, does not allow you to deposit or withdraw funds on the app – nor can you set up pricing alerts. For this, you’ll need to use your desktop device. Getting started at IG requires a minimum deposit of £250 – which you can do with a UK debit/credit card or bank account transfer. Finally, the platform.


  • Excellent reputation in the UK brokerage scene – Launched in 1974
  • Offers over 10,000 shares and funds
  • More than 17,000 CFD and spread betting markets offered
  • Buy UK shares from just £3 and US stocks from £0
  • Good research materials
  • Heavily regulated


  • iOS app is somewhat limited in functionality
  • 0.5%-1% charge on credit card deposits

Your capital is at risk

Step 2: Perform Research on Inovio Shares Before Investing

Before you proceed to buy Inovio shares – we would suggest taking a step back and performing some in-depth research. As we cover in more detail shortly – the firm has attracted a lot of attention recently as per its involvement in COV-19 clinical trials.

That is to say – Inovio is already in phase 2/3 of its clinical trials. If the firm is able to successfully move on to the next phase of testing – then we are likely to see a wave of investors jump on the Inovio bandwagon. But, if the opposite happens – maybe because the FDA puts a block on its trials – expect the opposite to happen.

Here’s what you need to know before you buy Inovio shares.

What is Inovio?

Inovio Cellectra deviceInovio is a US-based pharmaceutical company that is focused on biotechnologies. Its two main areas of research centre on cancer and infectious diseases. Regarding the latter, it is currently going all out on a potential vaccine for COV-19. This is why you might have only recently come across the Inovio brand – even though it was first launched in the late 1970s.

So where does Inovio stand in the race to find a coronavirus vaccine?

Well, it first announced to the public in January of this year that it had found a potential vaccine. This allowed the firm to get a head start over its pharmaceutical counterparts. It goes without saying that this had a positive impact on the firm’s previously stagnant stock price.

After its announcement, Inovio received interest from various donors. This includes a $5 million grant from the Bill and Melinda Gates Foundation, alongside a commitment of up to $9 million from the Coalition for Epidemic Preparedness Innovations. At the time of writing, Inovio is still in phase 2/3 of its clinical trials – as per a temporary suspension implemented by the FDA. More on this shortly. 

Inovio Shares: Historical Price Action 

By looking at the historical chart graphic below – it’s clear to see that Inovio shares are worth just a fraction of what they once were. Before we get to that – let’s quickly recap on where the stocks originally began their corporate journey. First and foremost, Inovio had its IPO way back in 1998 – where the shares were initially priced at $60 (adjusted for stock splits).

Innovio share price since IPO

Since its IPO, the company has initiated a single reverse stock split of 1-for-4 – which it did in 2014. For those unaware, this means that every 4 shares investors held – they would be left with just 1. Nevertheless, Inovio shares were initially well-received from the markets – going from $60 to $191 in the space of two years. However, the stocks then capitulated – going all of the way down to $2.50 in 2002.

To put this capitulation into perspective, this translates into a staggering decline of over 98% in less than 24 months. Since then, the stocks have managed the occasional upwards rally, albeit, this has been nowhere near its 2000 peak of $191. With that said, much of this is irrelevant in terms of investing in Inovio shares today, as much of its recent price action is based on its COV-19 vaccine clinical trials.

Innovio share price this year

Taking this into account, Inovio shares started the year at just over $3.20 each. On the back of its vaccine-related announcement – the shares naturally enjoyed some upwards momentum. In fact, the shares hit 52-week highs of just under $34 upon entering Q3. Inovio shares have, however, cooled off in recent weeks – with a current price of $12 each. This still translates into YTD returns of over almost 300%. 

Do Inovio Shares Pay Dividends?

Taking into account its capitulation since reaching peaks way back in 2000 – it will probably come as no surprise to learn that Inovio does not pay dividends. In fact, it has never made a dividend distribution since the company was launched in 1979. As a result, the only way that you will be able to increase the value of your investment is if Inovio shares go up in value.

Should I Buy Inovio Shares?

Put you simply – your ability to make money from an investment in Inovio is arguably dependent on how its COV-19 vaccine trials go. You won’t necessarily need Inovio to be the first pharmaceutical company in the world to win mass approval for its vaccine.

On the contrary, there will be plenty of short-term opportunities to make money – all of which will centre on its current clinical trials. That is to say, if Innovia gets the green light from the FDA to move to the next phase – then expect its stock price to react positively.

On the other hand, if Inovia is not successful with clinical trials – its stock could capitulate in a matter of days.

Phase 1 Clinical Trials

Although its phase 1 clinical trials began at the start of the year – it wasn’t until its earnings report of August that we got the full picture of patient response levels.

Crucially, the report noted that 100% of those that took part in the study developed an immune response to COV-19. These results have yet to be legitimised in a peer-review journey. But, Inovio has announced that this is a work-in-process.

Phase 2/3 Clinical Trials

Inovio awaits FDA verdictAs of October – Inovio is in phase 2/3 of its clinical trials. The key barrier here is that the FDA put a suspension on its trials last month – owing to additional questions that the agency needs answering. More specifically, this is related to Cellectra – a medical smart device that sits at the core of its COV-19 vaccine.

As the technology is not only proprietary – but relatively new, the FDA needs to explore Cellectra further before giving INovio the green light to resume trials.

With that being said, this is a temporary suspension as opposed to an outright block. In fact, the FDA will have to provide a response to Inovio’s reply within 30 days. The biotechnology firm is still working through this – meaning that the markets are in anticipation of what happens next.

It’s Surely a Punt, but the Upside Potential is Virtually Limitless 

If you’re looking for a risk-averse way to access the global stock markets – Inovio shares will not be for you. On the contrary – an investment into Inovio essentially offers a binary outcome. That is to say, if Inovio is not successful with its phase 2/3 clinical trials – then you should expect the worse. It goes without saying that investors will offload their shares in their drones – resulting in a complete stock market capitulation.

But, if – and this is, of course, a very significant ‘if’, Inovio is successful with not only with its phase 2/3 clinical trials but in being the first pharmaceutical ocm[pany to find a vaccine for COV-19 – the upside potential will be astronomical. In fact, we are talking about demand on a global scale in the billions of people that will in one way, shape, or form need access to the vaccine.

Step 3: Open a Stock Trading Account and Make a Deposit

If you are ready to buy Inovia shares right now from the comfort of your home – you will need to open a stock trading account with your chosen platform. The process should not take you money than 10 minutes when using our top-rated FCA platform

Note: If you are using – then you will be trading Inovio via CFD instruments. If you want to buy Inovio shares in the traditional sense – then you will be better suited for IG. 

Here’s what you need to do:

First and foremost, visit the website and open an account. This will require some personal information from you  – such as your name, home address, date of birth, and contact details.

inovio shares at

Next, you will be asked to make a deposit. If using a UK debit/credit card or e-wallet (such as Paypal) – you can deposit from just £20. The deposit will be processed instantly, too. This means that you buy Inovio shares straight away.

Note: As per FCA regulations on the countering of money laundering, will need to verify your identity. As is the case with most regulated platforms –  all you need to do is upload a copy of your passport or driver’s license. Additionally, you’ll need to supply a proof of address (such as a bank account statement). 

Step 4: Trade or Buy Inovio Shares Now

Once your account is opened and funded – it’s then just a case of placing an order. The platform offers a convenient search function – so just enter ‘Inovio’ into the box and click on the result that loads up.

inovio shares at

Then, click on ‘buy; if you think that the price of Inovio shares will increase or ‘sell’ if you think the price will go down.

inovio shares at

You then need to enter the amount that you wish to stake on your Inovio CFD trade. You are also offered the option of applying leverage (1:5) and setting up limit, stop-loss, and/or take-profit orders.

Finally, confirm the order and your Inovio share CFD trade will hit the markets. You can exit your position at any given time during stand market hours.

Inovio Shares Buy or Sell?

Whether or not you buy Inovio shares is dependent on how much risk you feel comfortable taking. After all, you not investing in a blue-chip company like Apple, IBM, or Ford Motors that has a proven business model. On the contrary, your share purchase is exclusively dependent on Inovio’s progress with the COV-19 trial.

The Verdict?

If you have a slightly higher appetite for risk and wish to take a chance on Inovio being successful with its phase 2/3 clinical trials – making an investment from the UK can be achieved in minutes.

If you decide to trade the company via CFDs – maybe because you want to apply leverage or benefit from 0% commission – then we would argue that FCA platform is the best option on the table. Opening an account takes minutes, you can deposit from just £20- – and debit/credit card and e-wallets are both instant and fee-free!

Simply click the link below to get started! – Trade Inovio Shares Commission-Free logo

72.6% of retail investor accounts lose money when trading CFDs with this provider.


What stock market are Inovio shares listed on?

Inovio is listed on the NASDAQ. This is the second-largest stock exchange in the world - one behind the New York Stock Exchange.

What is the Inovio stock price?

As of October 2020 - Inovio shares are priced in the $12 region. This represents YTD returns of almost 4x.

Does Inovio pay dividends?

Inovio does not pay dividends. In fact, it has not paid a dividend since it was launched almost four decades ago.

When did Inovio have its IPO?

Inovio had its IPO in 1998. Back then, the shares were priced at $60 (adjusted to take into account its 1-for-4 reverse stock split).

Can you trade Inovio shares with leverage?

Yes, if you're based in the UK and using a regulated CFD platform like - then you can trade Inovio shares with leverage of up to 1:5. Put simply, by meeting the minimum deposit of £100 - you can enter a buy or sell position worth up to £500.